Role of caudal epidural injections in the management of chronic low back pain

Abstract

Caudal epidural administration of corticosteroids is one of the commonly used interventions in managing chronic low back pain. Reports of the effectiveness of all types of epidural steroids have varied from 18% to 90%. Sicard, a radiologist, was the first to describe injection of dilute solutions of cocaine through the sacral hiatus into the epidural space in 1901, to treat patients suffering from severe, intractable sciatic pain or lumbago. This was followed by an explosion of reports and evolving interest in caudal epidural steroids with two additional reports in 1901 and numerous other reports over the years. The philosophy of epidural steroid injections is based on the premise that the corticosteroid delivered into the epidural space attains higher local concentrations over an inflamed nerve root and will be more effective than a steroid administered either orally or by intramuscular injection. The clinical effectiveness evaluations fill the literature with various types of reports including randomized clinical trials, prospective trials, retrospective studies, case reports, and meta-analyses. Evidence from all types of evaluations with regards to the clinical and cost-effectiveness of caudal epidural injections is encouraging. This review discusses various aspects of the role of caudal epidural injections in the management of chronic low back pain, including pathophysiology of low back pain, indications, clinical effectiveness and complications.